National Bank of Canada’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,250
| Closed | -$570 | – | 2720 |
|
|
2025
Q1 | $570 | Hold |
1,250
| – | – | ﹤0.01% | 2308 |
|
|
2024
Q4 | $629 | Buy |
1,250
+1,236
| +8,829% | +$622 | ﹤0.01% | 2319 |
|
|
2024
Q3 | $13 | Hold |
14
| – | – | ﹤0.01% | 2488 |
|
|
2024
Q2 | $13 | Hold |
14
| – | – | ﹤0.01% | 2518 |
|
|
2024
Q1 | $16 | Hold |
14
| – | – | ﹤0.01% | 2504 |
|
|
2023
Q4 | $15 | Hold |
14
| – | – | ﹤0.01% | 2506 |
|
|
2023
Q3 | $16 | Hold |
14
| – | – | ﹤0.01% | 2520 |
|
|
2023
Q2 | $20 | Hold |
14
| – | – | ﹤0.01% | 2527 |
|
|
2023
Q1 | $21 | Hold |
14
| – | – | ﹤0.01% | 2528 |
|
|
2022
Q4 | $16 | Hold |
14
| – | – | ﹤0.01% | 2569 |
|
|
2022
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 2595 |
|
|
2022
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 2651 |
|
|
2022
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 2682 |
|
|
2021
Q4 | $0 | Buy |
+14
| New | – | ﹤0.01% | 2597 |
|